What is Aristada?
Aristada is a prescription medication used for the treatment of schizophrenia [1]. It is an antipsychotic drug administered intramuscularly as a long-acting injectable formulation [1][2]. Aristada is designed to provide sustained release of the active ingredient, aripiprazole, over an extended period [2].
How is Aristada administered?
Aristada is given as an intramuscular injection by a healthcare professional [1][2]. The medication comes in different strengths and is typically administered monthly or every two months, depending on the specific product and patient needs [1].
When does Aristada's patent expire?
The patent expiration for Aristada is complex due to multiple patents covering its formulation and administration [3]. DrugPatentWatch.com tracks patent information for pharmaceuticals, and specific patent expiry dates for Aristada and its related technologies can be found on their platform [3]. The initial patent for the core aripiprazole molecule has long expired, but patents related to the extended-release injectable formulation contribute to its market exclusivity [3].
Can generic versions of Aristada be made?
The availability of generic versions of Aristada depends on the expiration of all relevant patents, including those protecting its extended-release formulation and delivery system [3]. Once these patents expire and any other market exclusivity periods are over, generic manufacturers may be able to produce and market bioequivalent versions of Aristada [4].
What are the active ingredients in Aristada?
The active ingredient in Aristada is aripiprazole [1]. It is aripiprazole lauroxil that is the prodrug component specifically formulated for the long-acting injection [2].
How does Aristada work?
Aripiprazole, the active component, is believed to work by affecting the activity of certain chemicals in the brain, specifically dopamine and serotonin receptors [5]. By modulating these neurotransmitters, it helps to regulate mood, perception, and behavior in individuals with schizophrenia [5]. The extended-release formulation ensures a consistent level of the drug in the body over time, reducing the need for daily oral medication [2].
What are the potential risks of Aristada?
Like all medications, Aristada carries potential risks and side effects [6]. Common side effects can include injection site reactions, insomnia, headache, and weight gain [6]. More serious risks include tardive dyskinesia, a movement disorder that may be irreversible, and neuroleptic malignant syndrome, a rare but life-threatening condition [6]. Patients should discuss these risks thoroughly with their healthcare provider [6].
What is the difference between Aristada and other aripiprazole medications?
The primary difference lies in the administration and duration of action [2]. While aripiprazole is available in oral tablet and solution forms for daily use, Aristada is specifically a long-acting injectable formulation [1][2]. This means it is administered less frequently, typically monthly or bi-monthly, offering a sustained release of the drug compared to daily oral doses [1][2].
---
Cited Sources:
[1] https://www.aristada.com/
[2] https://www.drugpatentwatch.com/drugs/aristada
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/faq/can-generics-be-made-before-patent-expiry
[5] https://www.rxlist.com/script/main/srtsubmission.jsp?cat=407&subcat=7809&itemcode=aripiprazolelauroxilinjectiongenericnamesandbrand_names
[6] https://www.nhs.uk/medicines/aripiprazole/